ZNF281 inhibits neuronal differentiation and is a prognostic marker for neuroblastoma
- PMID: 29941555
- PMCID: PMC6048510
- DOI: 10.1073/pnas.1801435115
ZNF281 inhibits neuronal differentiation and is a prognostic marker for neuroblastoma
Abstract
Derangement of cellular differentiation because of mutation or inappropriate expression of specific genes is a common feature in tumors. Here, we show that the expression of ZNF281, a zinc finger factor involved in several cellular processes, decreases during terminal differentiation of murine cortical neurons and in retinoic acid-induced differentiation of neuroblastoma (NB) cells. The ectopic expression of ZNF281 inhibits the neuronal differentiation of murine cortical neurons and NB cells, whereas its silencing causes the opposite effect. Furthermore, TAp73 inhibits the expression of ZNF281 through miR34a. Conversely, MYCN promotes the expression of ZNF281 at least in part by inhibiting miR34a. These findings imply a functional network that includes p73, MYCN, and ZNF281 in NB cells, where ZNF281 acts by negatively affecting neuronal differentiation. Array analysis of NB cells silenced for ZNF281 expression identified GDNF and NRP2 as two transcriptional targets inhibited by ZNF281. Binding of ZNF281 to the promoters of these genes suggests a direct mechanism of repression. Bioinformatic analysis of NB datasets indicates that ZNF281 expression is higher in aggressive, undifferentiated stage 4 than in localized stage 1 tumors supporting a central role of ZNF281 in affecting the differentiation of NB. Furthermore, patients with NB with high expression of ZNF281 have a poor clinical outcome compared with low-expressors. These observations suggest that ZNF281 is a controller of neuronal differentiation that should be evaluated as a prognostic marker in NB.
Keywords: MYCN; ZNF281; miR34a; neuroblastoma; p73.
Copyright © 2018 the Author(s). Published by PNAS.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Incorporating genomic, transcriptomic and clinical data: a prognostic and stem cell-like MYC and PRC imbalance in high-risk neuroblastoma.BMC Syst Biol. 2017 Oct 3;11(Suppl 5):92. doi: 10.1186/s12918-017-0466-5. BMC Syst Biol. 2017. PMID: 28984200 Free PMC article.
-
The deubiquitinating enzyme UCHL1 is a favorable prognostic marker in neuroblastoma as it promotes neuronal differentiation.J Exp Clin Cancer Res. 2018 Oct 25;37(1):258. doi: 10.1186/s13046-018-0931-z. J Exp Clin Cancer Res. 2018. PMID: 30359286 Free PMC article.
-
MYCN-amplified neuroblastoma maintains an aggressive and undifferentiated phenotype by deregulation of estrogen and NGF signaling.Proc Natl Acad Sci U S A. 2018 Feb 6;115(6):E1229-E1238. doi: 10.1073/pnas.1710901115. Epub 2018 Jan 26. Proc Natl Acad Sci U S A. 2018. PMID: 29374092 Free PMC article.
-
ZNF281/ZBP-99: a new player in epithelial-mesenchymal transition, stemness, and cancer.J Mol Med (Berl). 2014 Jun;92(6):571-81. doi: 10.1007/s00109-014-1160-3. Epub 2014 May 18. J Mol Med (Berl). 2014. PMID: 24838609 Review.
-
Recent advances in the developmental origin of neuroblastoma: an overview.J Exp Clin Cancer Res. 2022 Mar 11;41(1):92. doi: 10.1186/s13046-022-02281-w. J Exp Clin Cancer Res. 2022. PMID: 35277192 Free PMC article. Review.
Cited by
-
EIF4EBP1 is transcriptionally upregulated by MYCN and associates with poor prognosis in neuroblastoma.Cell Death Discov. 2022 Apr 4;8(1):157. doi: 10.1038/s41420-022-00963-0. Cell Death Discov. 2022. PMID: 35379801 Free PMC article.
-
ZNF281 inhibits mitochondrial biogenesis to facilitate metastasis of hepatocellular carcinoma.Cell Death Discov. 2023 Oct 25;9(1):396. doi: 10.1038/s41420-023-01691-9. Cell Death Discov. 2023. PMID: 37880213 Free PMC article.
-
Understanding the regulation of β-catenin expression and activity in colorectal cancer carcinogenesis: beyond destruction complex.Clin Transl Oncol. 2021 Dec;23(12):2448-2459. doi: 10.1007/s12094-021-02686-7. Epub 2021 Aug 23. Clin Transl Oncol. 2021. PMID: 34426910 Review.
-
The comprehensive landscape of miR-34a in cancer research.Cancer Metastasis Rev. 2021 Sep;40(3):925-948. doi: 10.1007/s10555-021-09973-3. Epub 2021 May 6. Cancer Metastasis Rev. 2021. PMID: 33959850 Review.
-
Biomarkers in Neuroblastoma: An Insight into Their Potential Diagnostic and Prognostic Utilities.Curr Treat Options Oncol. 2021 Sep 27;22(11):102. doi: 10.1007/s11864-021-00898-1. Curr Treat Options Oncol. 2021. PMID: 34580780 Review.
References
-
- Kaghad M, et al. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell. 1997;90:809–819. - PubMed
-
- Pozniak CD, et al. An anti-apoptotic role for the p53 family member, p73, during developmental neuron death. Science. 2000;289:304–306. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous
